共 146 条
[1]
Sellier-Leclerc A-L(2012)Rituximab in steroid-dependent idiopathic nephrotic syndrome in childhood--follow-up after CD19 recovery Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc 27 1083-1089
[2]
Baudouin V(2010)Single infusion of rituximab for persistent steroid-dependent minimal-change nephrotic syndrome after long-term cyclosporine Pediatr Nephrol Berl Ger 25 539-544
[3]
Kwon T(2016)B Cell Reconstitution after Rituximab Treatment in Idiopathic Nephrotic Syndrome J Am Soc Nephrol JASN 27 1811-1822
[4]
Macher M-A(2008)Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases Pediatr Nephrol Berl Ger 23 1269-1279
[5]
Guérin V(2010)Rituximab efficiency in children with steroid-dependent nephrotic syndrome Pediatr Nephrol Berl Ger 25 1109-1115
[6]
Lapillonne H(2013)Novel use of rituximab for steroid-dependent nephrotic syndrome in children Am J Nephrol 38 483-488
[7]
Deschênes G(2014)PD42 - Is rituximab a trigger for persistent hypogammaglobulinemia in idiopathic nephrotic syndrome? Clin Transl Allergy 4 P42-65
[8]
Ulinski T(2018)Association of Immunoglobulin Levels, Infectious Risk, and Mortality With Rituximab and Hypogammaglobulinemia JAMA Netw Open 1 60-1824
[9]
Fujinaga S(2015)Rituximab-associated hypogammaglobulinemia: incidence, predictors and outcomes in patients with multi-system autoimmune disease J Autoimmun 57 1818-451
[10]
Hirano D(2014)Serum immunoglobulin levels and risk factors for hypogammaglobulinaemia during long-term maintenance therapy with rituximab in patients with granulomatosis with polyangiitis Rheumatol Oxf Engl 53 447-345